Coagulation Cascade - Easy Way To Remember Intrinsic vs Extrinsic Pathways | PT or PTT?

Summary

This video provides a comprehensive overview of the coagulation cascade, breaking down the intrinsic, extrinsic, and common pathways, their key factors, and associated lab tests (PT and PTT). It explains the role of vitamin K–dependent factors, common causes of abnormal coagulation tests, and the mechanisms of anticoagulant drugs including heparin, low molecular weight heparins, warfarin, and direct oral anticoagulants. The speaker also shares memorable tricks to recall pathways, factors, and lab assessments. Additionally, the video covers reversal strategies for anticoagulants, highlighting antidotes like protamine sulfate, vitamin K, fresh frozen plasma, monoclonal antibodies, and newly approved agents, making complex coagulation concepts accessible and memorable.

Takeaways

• 😀 The coagulation cascade is a complex process frequently revisited in medical school, involving both intrinsic and extrinsic pathways.
• 😀 The intrinsic pathway is activated by surface damage and includes factors 12, 11, 9, and 8, while the extrinsic pathway is triggered by trauma and involves tissue factor (factor 3) and activated factor 7.
• 😀 Both pathways converge at factor 10, which is the point where the intrinsic and extrinsic pathways meet, leading to the common pathway.
• 😀 The common pathway is where activated factor 10 converts prothrombin into thrombin, which then cleaves fibrinogen into fibrin, forming a clot.
• 😀 Factor 5 is an essential cofactor for the activation of factor 10 in the common pathway, and it requires calcium to function effectively.
• 😀 The intrinsic pathway can be remembered using a countdown: 12, 11, 9, 8, while the extrinsic pathway can be linked to the sum of factors 7 and 3, which adds up to 10 (X).
• 😀 The activated partial thromboplastin time (PTT) test evaluates the intrinsic pathway, while the prothrombin time (PT) test assesses the extrinsic pathway. Both tests also evaluate the common pathway.
• 😀 The normal range for PTT is 25-29 seconds, while PT typically ranges around 12 seconds, though these can vary across labs.
• 😀 Vitamin K-dependent factors include factors 2, 7, 9, and 10. Deficiencies in these can lead to prolonged PT or PTT values.
• 😀 Heparin works by enhancing the activity of antithrombin 3 to inhibit activated factor 10 and thrombin, while low molecular weight heparins specifically target activated factor 10.
• 😀 Warfarin inhibits vitamin K reductase, leading to a decrease in vitamin K-dependent factors. It often requires bridging therapy with heparin to be effective, as its effects take time to manifest.
• 😀 Direct oral anticoagulants (DOACs) like rivaroxaban and apixaban directly inhibit activated factor 10, while dabigatran and argatroban directly inhibit thrombin.
• 😀 The antidote to heparin is protamine sulfate, while vitamin K is used for warfarin reversal. Fresh frozen plasma and prothrombin complex concentrate can also be used for immediate warfarin reversal.
• 😀 Specific monoclonal antibodies and recently approved agents like andexanet alfa are used to reverse the effects of DOACs.

Q & A

What is the coagulation cascade, and why is it important in medical studies?

The coagulation cascade is a complex series of events that leads to blood clotting. It's essential in medical studies because understanding the cascade helps in diagnosing and treating bleeding disorders, managing anticoagulant therapy, and addressing clotting complications.

What are the key factors involved in the intrinsic pathway of the coagulation cascade?

The intrinsic pathway involves factors 12, 11, 9, and 8. It is activated by surface damage, leading to a cascade of reactions ultimately resulting in the activation of factor 10.

How is the extrinsic pathway activated, and which factors are involved?

The extrinsic pathway is activated by trauma or inflammation that releases tissue factor (factor 3). The tissue factor binds with activated factor 7 to form a complex that activates factor 10.

What role does factor 10 play in the coagulation cascade?

Activated factor 10 (factor Xa) is crucial in converting prothrombin into active thrombin (factor 2), which then cleaves fibrinogen into fibrin, ultimately leading to clot formation.

What is the function of factor 5 in the coagulation cascade?

Factor 5 acts as a cofactor in the coagulation cascade. It is required alongside calcium to activate factor 10, facilitating the conversion of prothrombin into thrombin.

How can you differentiate the intrinsic and extrinsic pathways?

A simple way to differentiate the pathways is through counting. The intrinsic pathway is remembered by the countdown 12, 11, 9, 8, while the extrinsic pathway involves factors 7 and 3, which add up to 10 (representing the common pathway).

What tests are used to assess the intrinsic and extrinsic pathways, and how can you remember which test evaluates each?

The activated partial thromboplastin time (aPTT or PTT) is used to assess the intrinsic pathway, and prothrombin time (PT) is used for the extrinsic pathway. A mnemonic to remember this is 'You play table tennis inside' for PTT (intrinsic) and 'You play tennis outside' for PT (extrinsic).

What is the significance of vitamin K in the coagulation process?

Vitamin K is essential for the synthesis of vitamin K-dependent factors (2, 7, 9, and 10). Without activated vitamin K, these factors cannot be formed, leading to clotting issues and prolonged PT or PTT times.

How do anticoagulant drugs like heparin, warfarin, and DOACs (direct oral anticoagulants) work?

Heparin enhances antithrombin III, inhibiting factors 10 and thrombin. Warfarin inhibits vitamin K reductase, reducing vitamin K-dependent factors. DOACs directly inhibit either factor 10 or thrombin, reducing clot formation.

What is the role of antidotes in reversing anticoagulation effects, and how do they work?

Antidotes reverse the effects of anticoagulants. Protamine sulfate reverses heparin, vitamin K reverses warfarin, and monoclonal antibodies like idarucizumab and andexanet alfa reverse direct thrombin inhibitors and factor 10 inhibitors, respectively.